CHMP Meets To Discuss Avandia And Pandemrix, Europe

Links shared publicly online about this topic.

886
total visits

CHMP Meets To Discuss Avandia And Pandemrix, Europe

The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and A

View full resource at medicalnewstoday.com

Tags: Diabetes Type 2 Medication, Diabetes Medication, Avandia, Avandamet

Most Recently Shared on September 9, 2010 at 3:00 pm By:

MNT Diabetes News

CHMP Meets To Discuss Avandia And Pandemrix, Europe http://mnt.to/3Jvv #diabetes

2 years ago...

Retweet

Favorite

Also Shared By:

Heart Health

MNT Cardiovascular

CHMP Meets To Discuss Avandia And Pandemrix, Europe - QualityPoint Technologies

qualitypointtech.net — “The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and Avaglim. The Committee discussed all of the available data on the risk of cardiovascular problems associated with rosiglitazone in order to prepare for its next scheduled meeting of 20-23 September 2010, when it expects to finalise its review. The CHMP identified a number of further questions that it is ” View full resource at qualitypointtech.net